Navigation Links
ViroPharma Initiates Phase 2 Study of VP 20621 for Prevention of Recurrence of Clostridium difficile Infection (CDI)
Date:5/19/2011

ults of the Phase 2 study may not be predictive of how VP 20621 will perform in future studies. There can be no assurance that we will conduct additional studies with VP 20621 in the timeframes we expect or at all, or that VP 20621 can significantly reduce the incidence of recurrent disease for patients with CDI. The FDA or EMA may view the data regarding VP 20621 as insufficient or inconclusive, request additional data, require additional clinical studies, delay any decision past the time frames anticipated by us, limit any approved indications, or deny the approval of VP 20621. These factors, and other factors, including, but not limited to those described in ViroPharma's annual report on Form 10-K and quarterly reports on Form 10-Q filed with the Securities and Exchange Commission during 2010, could cause future results to differ materially from the expectations expressed in this press release. The forward-looking statements contained in this press release may become outdated over time. ViroPharma does not assume any responsibility for updating any forward-looking statements.  These forward-looking statements should not be relied upon as representing our assessments as of any date subsequent to the date of this press release.


'/>"/>
SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. ViroPharma to Present at Three Upcoming Healthcare Conferences
2. ViroPharma to Present at the Natixis Bleichroeder Conference
3. ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
4. ViroPharma to Release 2008 First Quarter Financial Results on April 30, 2008
5. ViroPharma Announces Discontinuation of HCV-796 Development
6. ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients
7. ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
8. ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema
9. ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
10. ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance
11. ViroPharma Incorporated Reports Third Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... , July 23, 2014  Mevesi Inc. ... Fresh Media. This integration provides pharmacies with the ... current and prospective patients. Mevesi,s ... local consumer data to define target marketing campaigns. ... marketing capabilities available within the Digital Marketing, Population ...
(Date:7/23/2014)... 23, 2014  Silk Road Medical, Inc., a ... of intra- and extra-cranial cerebrovascular disease, announced today ... to the position of Chief Technology Officer.  In ... Research and Development efforts across its family of ... Prior to joining Silk Road Medical, Michael was ...
(Date:7/23/2014)... , July 23 2014 Ampio Pharmaceuticals, Inc. ... new headquarters, manufacturing and research facility: Ampio ... 80112 Direct: (720) 437-6500 Michael ... pharmaceutical drug manufacturing facility will be fully operational this ... first batches of Ampion TM necessary to accommodate ...
Breaking Medicine Technology:Mevesi Enhances Solutions with Variable Print Media Capabilities! 2Silk Road Medical Appoints Ground Breaking Innovator as Chief Technology Officer 2Silk Road Medical Appoints Ground Breaking Innovator as Chief Technology Officer 3Ampio Pharmaceuticals announces the opening of its new headquarters, manufacturing and research facility in Englewood Colorado 2
... Surgical Company (Nasdaq: STAA ), the leading ... today announced that the Visian Implantable Collamer® Lens (ICL) ... leading ophthalmologists at meetings prior to and during the ... Surgeons (ESCRS) held in Paris, France from September 4 ...
... Present at the Rodman & Renshaw Annual Global... -- SHENZHEN, China, Sept. 8 /PRNewswire-Asia/ -- ... ... --> ... var s = ,; var first_result; // Results are keyed by longUrl, so we need to grab ...
Cached Medicine Technology:STAAR Surgical Launches New Visian ICL™ Product Line Extensions at ESCRS 2STAAR Surgical Launches New Visian ICL™ Product Line Extensions at ESCRS 3STAAR Surgical Launches New Visian ICL™ Product Line Extensions at ESCRS 4STAAR Surgical Launches New Visian ICL™ Product Line Extensions at ESCRS 5STAAR Surgical Launches New Visian ICL™ Product Line Extensions at ESCRS 6Winner Medical Group Inc. to Present at the Rodman & Renshaw Annual Global Investment Conference on September 13 at 3:40 pm ET 2Winner Medical Group Inc. to Present at the Rodman & Renshaw Annual Global Investment Conference on September 13 at 3:40 pm ET 3Winner Medical Group Inc. to Present at the Rodman & Renshaw Annual Global Investment Conference on September 13 at 3:40 pm ET 4Winner Medical Group Inc. to Present at the Rodman & Renshaw Annual Global Investment Conference on September 13 at 3:40 pm ET 5Winner Medical Group Inc. to Present at the Rodman & Renshaw Annual Global Investment Conference on September 13 at 3:40 pm ET 6Winner Medical Group Inc. to Present at the Rodman & Renshaw Annual Global Investment Conference on September 13 at 3:40 pm ET 7
(Date:7/23/2014)... NY (PRWEB) July 23, 2014 The ... billion dollars by the year 2020, according to recent ... are among the top sellers in the U.S. and ... best wrinkle cream under $100 is now reviewed at ... to help a first-time or experienced shopper to compare ...
(Date:7/23/2014)... The age spots, wrinkles and puffy eyes that ... 30 are now explored in a new guide posted at ... for women over 30 are introduced in the guide as ... The use of creams as an alternative to surgery is ... according to the information in the new guide. Because there ...
(Date:7/23/2014)... Recently, iFitDress.com, a professional company of women’s ... 2014 vintage party dresses . Aside from that, it ... discount is up to 63% off. , “We are excited ... new items are all manufactured by trustworthy and experienced workers ... July 30; it is great to provide such a great ...
(Date:7/23/2014)... July 23, 2014 A new study ... power morcellator ( http://www.injurybeacon.com/power-morcellator/ ) during minimally invasive ... throughout a woman’s body, Bernstein Liebhard LLP reports. The ... Journal of the American Medical Association, looked at 36,000 ... at 500 U.S. hospitals from 2006 to 2012. Ninety-nine ...
(Date:7/23/2014)... By Steven Reinberg ... (HealthDay News) -- Many obese and overweight American children ... their weight is fine, U.S. health officials reported Wednesday. ... health outcomes, such as high blood pressure, high cholesterol ... epidemiologist at the U.S. Centers for Disease Control and ...
Breaking Medicine News(10 mins):Health News:Best Wrinkle Cream Under $100 Reviewed at Top News Website Online 2Health News:Best Eye Creams for Women Over 30 Detailed in Published Guide at News Website Online 2Health News:Cheap 2014 Vintage Party Dresses From Professional Supplier iFitDress.com 2Health News:Power Morcellator News: Bernstein Liebhard LLP Notes Publication of New Study Confirming Potential for Uterine Morcellation to Spread Undetected Cancer 2Health News:Power Morcellator News: Bernstein Liebhard LLP Notes Publication of New Study Confirming Potential for Uterine Morcellation to Spread Undetected Cancer 3Health News:Power Morcellator News: Bernstein Liebhard LLP Notes Publication of New Study Confirming Potential for Uterine Morcellation to Spread Undetected Cancer 4Health News:Many Obese U.S. Kids Think They're Thinner Than They Are 2Health News:Many Obese U.S. Kids Think They're Thinner Than They Are 3
... as $500 would have "severe" impact on financial stability ... to climb, one often overlooked aspect of people being ... national recent survey conducted by Affinion Group, a leading ... to living paycheck-to-paycheck "often" or "always." The survey questioned ...
... Fiscal third quarter revenue from continuing operations increased $25 million, or 5%, ... , , , ... , , , , , ... , , , , , ...
... (NYSE: STE ) today announced that its Board ... dividend to $0.11 per common share. The dividend is ... close of business on May 21, 2009. About STERIS ... a healthier today and safer tomorrow through knowledgeable people and ...
... Significantly , , PRINCETON, N.J. May ... a leading worldwide provider of identity DNA testing services, today ... revenues were $14.0 million for the first quarter of 2009 ... despite the adverse impact of foreign exchange rates which reduced ...
... CARY, N.C., May 7 Cornerstone Therapeutics Inc. (Nasdaq CM: CRTX), ... products primarily for the respiratory market, today reported financial results for ... , ... or 225% , , , ...
... 10-YEAR LICENSE FOR U.S. COMMERCIAL RIGHTS TO MARKETED ... $15.5 MILLION- CORNERSTONE RECEIVES FIRST RIGHT OF OFFER ... IN THE U.S.CARY, N.C., May 7 Cornerstone ... company focused on acquiring, developing and commercializing prescription ...
Cached Medicine News:Health News:Affinion Group Survey Reveals That Underinsured Consumers Need Alternate Solutions in Light of Current Economic Climate 2Health News:Affinion Group Survey Reveals That Underinsured Consumers Need Alternate Solutions in Light of Current Economic Climate 3Health News:Perrigo Reports Record Third Quarter 2Health News:Perrigo Reports Record Third Quarter 3Health News:Perrigo Reports Record Third Quarter 4Health News:Perrigo Reports Record Third Quarter 5Health News:Perrigo Reports Record Third Quarter 6Health News:Perrigo Reports Record Third Quarter 7Health News:Perrigo Reports Record Third Quarter 8Health News:Perrigo Reports Record Third Quarter 9Health News:Perrigo Reports Record Third Quarter 10Health News:Perrigo Reports Record Third Quarter 11Health News:Perrigo Reports Record Third Quarter 12Health News:Perrigo Reports Record Third Quarter 13Health News:Perrigo Reports Record Third Quarter 14Health News:Perrigo Reports Record Third Quarter 15Health News:Perrigo Reports Record Third Quarter 16Health News:Perrigo Reports Record Third Quarter 17Health News:Perrigo Reports Record Third Quarter 18Health News:Perrigo Reports Record Third Quarter 19Health News:Perrigo Reports Record Third Quarter 20Health News:Perrigo Reports Record Third Quarter 21Health News:Perrigo Reports Record Third Quarter 22Health News:STERIS Corporation Announces Quarterly Dividend Increase of 38% 2Health News:STERIS Corporation Announces Quarterly Dividend Increase of 38% 3Health News:Orchid Cellmark Reports Improved First Quarter 2009 Financial Results 2Health News:Orchid Cellmark Reports Improved First Quarter 2009 Financial Results 3Health News:Orchid Cellmark Reports Improved First Quarter 2009 Financial Results 4Health News:Orchid Cellmark Reports Improved First Quarter 2009 Financial Results 5Health News:Orchid Cellmark Reports Improved First Quarter 2009 Financial Results 6Health News:Orchid Cellmark Reports Improved First Quarter 2009 Financial Results 7Health News:Orchid Cellmark Reports Improved First Quarter 2009 Financial Results 8Health News:Orchid Cellmark Reports Improved First Quarter 2009 Financial Results 9Health News:Cornerstone Therapeutics Reports First Quarter 2009 Financial Results 2Health News:Cornerstone Therapeutics Reports First Quarter 2009 Financial Results 3
Mounted on a sturdy, molded headband,the Classic has a fully adjustable crown,strap and cushioning that adds to,your comfort....
The Convertible lets you attach the,High Lite optic directly to your loupes....
... is a product of AlloSource, one ... human tissue processing, and Interpore Cross, ... InterGro combines AlloGro DBM with ... deliver a unique bone graft that ...
Immunoassay for the detection of Group A streptococcal antigen directly from throat swab specimens. ,Rapid, accurate diagnosis assures prompt treatment....
Medicine Products: